bioAffinity Technologies(BIAF) - 2025 Q3 - Quarterly Results

bioAffinity Technologies Reports Third Quarter 2025 Financial Results Exhibit 99.1 SAN ANTONIO, Texas – November 14, 2025 – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on providing noninvasive, accurate detection of early-stage lung cancer and other lung diseases, today reported financial results for the three months ended September 30, 2025. Key Highlights Company achieves 86% increase in CyPath Lung testing revenue, strengthens balance sheet -1- ● CyPath Lung reve ...